| MOPEA11 | Longitudinal profiling of immune responses to simian immunodeficiency virus throughout disease progression and antiretroviral treatment | Poster exhibition | Host immune responses, vaccines and immunotherapies |
| OAA0402 | Novel V1 deleted-envelope vaccine based on VLP protects against SHIV infection | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| OAA0403 | Perturbation of mucosal granulocytic effector cells in lentivirus infections | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| OAA0404 | Diverse envelope trimers with altered glycan coverage around the CD4-binding site elicit neutralizing antibodies of >50% breadth in NHPs | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| OALBX0104 | Sustained aviraemia in the absence of anti-retroviral therapy in male children following in utero vertical HIV transmission | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| EPE1004 | Preferred models of clinical service delivery for HIV pre-exposure prophylaxis (PrEP) users in the COVID-19 era: a discrete choice experiment among men who have sex with men (MSM) in Australia | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| EPE1005 | Compounding factors that affected viral load scale-up and viral load coverage in Kenya, before and during the COVID-19 pandemic | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| EPE1006 | Identifying the drivers and influencers of COVID-19 vaccine hesitancy in Nigeria | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| EPE1007 | Delivering HIV pre-exposure prophylaxis to people who use drugs experiencing homelessness during the COVID-19 pandemic | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |
| EPE1008 | PrEP use behaviors and sexual health in China during COVID-19 lockdowns | E-poster | Impact of COVID-19 on HIV prevention, testing and treatment (including financing) |